Cancer mutations could result in incomplete EDVP complex formation, and incomplete EDVP can exhibit oncogenic prosurvival role because DYRK2+EDD alone degrades the proapoptotic factor modulator of apoptosis protein 1 independently of DDB1 and VPRBP in ovarian cancer (89). Here, DYRK2 is linked to ovarian carcinoma.